Zymosan by-passes the requirement for pulmonary antigen encounter in lung tissue-resident memory CD8


Journal

Mucosal immunology
ISSN: 1935-3456
Titre abrégé: Mucosal Immunol
Pays: United States
ID NLM: 101299742

Informations de publication

Date de publication:
03 2019
Historique:
received: 11 05 2018
accepted: 05 12 2018
revised: 04 11 2018
pubmed: 22 1 2019
medline: 25 6 2019
entrez: 22 1 2019
Statut: ppublish

Résumé

Tissue-resident memory T cells (Trm) in the lung provide a frontline defence against respiratory pathogens. Vaccination models that lodge CD8

Identifiants

pubmed: 30664708
doi: 10.1038/s41385-018-0124-2
pii: S1933-0219(22)00387-7
doi:

Substances chimiques

Adjuvants, Immunologic 0
Antigens 0
Influenza Vaccines 0
Lectins, C-Type 0
dectin 1 0
Zymosan 9010-72-4

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

403-412

Références

Pizzolla A, Nguyen THO, Smith JM, Brooks AG, Kedzieska K, Heath WR et al. Resident memory CD8+T cells in the upper respiratory tract prevent pulmonary influenza virus infection. Sci. Immunol. 2, pii: eaam6970 (2017).
doi: 10.1126/sciimmunol.aam6970
Wu, T., Hu, Y., Lee, Y. T., Bouchard, K. R., Benechet, A. & Khanna, K. et al. Lung-resident memory CD8 T cells (TRM) are indispensable for optimal cross-protection against pulmonary virus infection. J. Leukoc. Biol. 95, 215–24 (2014).
doi: 10.1189/jlb.0313180
Wakim, L. M., Smith, J., Caminschi, I., Lahoud, M. H. & Villadangos, J. A. Antibody-targeted vaccination to lung dendritic cells generates tissue-resident memory CD8 T cells that are highly protective against influenza virus infection. Mucosal Immunol. 8, 1060–71 (2015).
doi: 10.1038/mi.2014.133
Turner DL, Bickham KL, Thome JJ, Kim CY, D’Ovidio F, Wherry EJ et al. Lung niches for the generation and maintenance of tissue-resident memory T cells. Mucosal Immunol. 7, 501–10 (2013).
doi: 10.1038/mi.2013.67
Zens KD, Chen JK, Farber DL. Vaccine-generated lung tissue-resident memory T cells provide heterosubtypic protection to influenza infection. JCI Insight 1, pii: e85832 (2016).
Jozwik, A., Habibi, M. S., Paras, A., Zhu, J., Guvenel, A. & Dhariwal, J. et al. RSV-specific airway resident memory CD8+T cells and differential disease severity after experimental human infection. Nat. Commun. 6, 10224 (2015).
doi: 10.1038/ncomms10224
Zhao, J., Zhao, J., Mangalam, A. K., Channappanavar, R., Fett, C. & Meyerholz, D. K. et al. Airway memory CD4(+) T cells mediate protective immunity against emerging respiratory coronaviruses. Immunity 44, 1379–91 (2016).
doi: 10.1016/j.immuni.2016.05.006
Mueller, S. N. & Mackay, L. K. Tissue-resident memory T cells: local specialists in immune defence. Nat. Rev. Immunol. 16, 79–89 (2016).
doi: 10.1038/nri.2015.3
Mackay LK, Rahimpour A, Ma JZ, Collins N, Stock AT, Hafon ML et al. The developmental pathway for CD103CD8 tissue-resident memory T cells of skin. Nat. Immunol. 14, 1294–301 (2013).
doi: 10.1038/ni.2744
Wakim, L. M., Woodward-Davis, A., Liu, R., Hu, Y., Villadangos, J. & Smyth, G. et al. The molecular signature of tissue resident memory CD8 T cells isolated from the brain. J. Immunol. 189, 3462–71 (2012).
doi: 10.4049/jimmunol.1201305
Hombrink, P., Helbig, C., Backer, R. A., Piet, B., Oja, A. E. & Stark, R. et al. Programs for the persistence, vigilance and control of human CD8+lung-resident memory T cells. Nat. Immunol. 17, 1467–78 (2016).
doi: 10.1038/ni.3589
Kumar, B. V., Ma, W., Miron, M., Granot, T., Guyer, R. S. & Carpenter, D. J. et al. Human tissue-resident memory T cells are defined by core transcriptional and functional signatures in lymphoid and mucosal sites. Cell Rep. 20, 2921–34 (2017).
doi: 10.1016/j.celrep.2017.08.078
Skon, C. N., Lee, J. Y., Anderson, K. G., Masopust, D., Hogquist, K. A. & Jameson, S. C. Transcriptional downregulation of S1pr1 is required for the establishment of resident memory CD8+T cells. Nat. Immunol. 14, 1285–93 (2013).
doi: 10.1038/ni.2745
Mackay, L. K., Wynne-Jones, E., Freestone, D., Pellicci, D. G., Mielke, L. A. & Newman, D. M. et al. T-box transcription factors combine with the cytokines TGF-beta and IL-15 to control tissue-resident memory T cell fate. Immunity 43, 1101–11 (2015).
doi: 10.1016/j.immuni.2015.11.008
Mackay, L. K., Minnich, M., Kragten, N. A., Liao, Y., Nota, B. & Seillet, C. et al. Hobit and Blimp1 instruct a universal transcriptional program of tissue residency in lymphocytes. Science 352, 459–63 (2016).
doi: 10.1126/science.aad2035
Ariotti, S., Hogenbirk, M. A., Dijkgraaf, F. E., Visser, L. L., Hoekstra, M. E. & Song, J. Y. et al. T cell memory. Skin-resident memory CD8(+) T cells trigger a state of tissue-wide pathogen alert. Science 346, 101–5 (2014).
doi: 10.1126/science.1254803
Schenkel, J. M., Fraser, K. A., Vezys, V. & Masopust, D. Sensing and alarm function of resident memory CD8(+) T cells. Nat. Immunol. 14, 509–13 (2013).
doi: 10.1038/ni.2568
Hu, Y., Lee, Y. T., Kaech, S. M., Garvy, B. & Cauley, L. S. Smad4 promotes differentiation of effector and circulating memory CD8 T cells but is dispensable for tissue-resident memory CD8 T cells. J. Immunol. 194, 2407–14 (2015).
doi: 10.4049/jimmunol.1402369
Hu, Y. & Cauley, L. Antigen and transforming growth factor Beta receptors contribute to long term functional and phenotypic heterogeneity of memory CD8 T cells. Front. Immunol. 4, 227 (2013).
doi: 10.3389/fimmu.2013.00227
Laidlaw, B. J., Zhang, N., Marshall, H. D., Staron, M. M., Guan, T. & Hu, Y. et al. CD4+T cell help guides formation of CD103+lung-resident memory CD8+T cells during influenza viral infection. Immunity 41, 633–45 (2014).
doi: 10.1016/j.immuni.2014.09.007
Takamura, S., Yagi, H., Hakata, Y., Motozono, C., McMaster, S. R. & Masumoto, T. et al. Specific niches for lung-resident memory CD8+T cells at the site of tissue regeneration enable CD69-independent maintenance. J. Exp. Med 213, 3057–73 (2016).
doi: 10.1084/jem.20160938
McMaster SR, Wein AN, Dunbar PR, Hayward SL, Cartwright EK, Denning TL et al. Pulmonary antigen encounter regulates the establishment of tissue-resident CD8 memory T cells in the lung airways and parenchyma. Mucosal Immunol. 11, 1071–1078 (2018).
doi: 10.1038/s41385-018-0003-x
Wakim, L. M., Gupta, N., Mintern, J. D. & Villadangos, J. A. Enhanced survival of lung tissue-resident memory CD8( + ) T cells during infection with influenza virus due to selective expression of IFITM3. Nat. Immunol. 14, 238–45 (2013).
doi: 10.1038/ni.2525
Muschaweckh A, Buchholz VR, Fellenzer A, Hessel C, Konig PA, Tao S et al. Antigen-dependent competition shapes the local repertoire of tissue-resident memory CD8+T cells. J. Exp. Med. 213, 3075–3086 (2016).
doi: 10.1084/jem.20160888
Gebhardt, T., Wakim, L. M., Eidsmo, L., Reading, P. C., Heath, W. R. & Carbone, F. R. Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus. Nat. Immunol. 10, 524–30 (2009).
doi: 10.1038/ni.1718
Shin, H. & Iwasaki, A. A vaccine strategy that protects against genital herpes by establishing local memory T cells. Nature 491, 463–7 (2012).
doi: 10.1038/nature11522
Bergsbaken, T. & Bevan, M. J. Proinflammatory microenvironments within the intestine regulate the differentiation of tissue-resident CD8(+) T cells responding to infection. Nat. Immunol. 16, 406–14 (2015).
doi: 10.1038/ni.3108
Gilchuk, P., Hill, T. M., Guy, C., McMaster, S. R., Boyd, K. L. & Rabacal, W. A. et al. A distinct lung-interstitium-resident memory CD8(+) T cell subset confers enhanced protection to lower respiratory tract infection. Cell Rep. 16, 1800–9 (2016).
doi: 10.1016/j.celrep.2016.07.037
Deliyannis, G., Kedzierska, K., Lau, Y. F., Zeng, W., Turner, S. J. & Jackson, D. C. et al. Intranasal lipopeptide primes lung-resident memory CD8+T cells for long-term pulmonary protection against influenza. Eur. J. Immunol. 36, 770–8 (2006).
doi: 10.1002/eji.200535217
Gasper, D. J., Neldner, B., Plisch, E. H., Rustom, H., Carrow, E. & Imai, H. et al. Effective respiratory CD8 T-cell immunity to influenza virus induced by intranasal carbomer-lecithin-adjuvanted non-replicating vaccines. PLoS Pathog. 12, e1006064 (2016).
doi: 10.1371/journal.ppat.1006064
Underhill, D. M. Macrophage recognition of zymosan particles. J. Endotoxin Res. 9, 176–80 (2003).
doi: 10.1177/09680519030090030601
Reid, D. M., Gow, N. A. & Brown, G. D. Pattern recognition: recent insights from Dectin-1. Curr. Opin. Immunol. 21, 30–37 (2009).
doi: 10.1016/j.coi.2009.01.003
Takeuchi, K., Umeki, Y., Matsumoto, N., Yamamoto, K., Yoshida, M. & Suzuki, K. et al. Severe neutrophil-mediated lung inflammation in myeloperoxidase-deficient mice exposed to zymosan. Inflamm. Res. 61, 197–205 (2012).
doi: 10.1007/s00011-011-0401-y
Dillon, S., Agrawal, S., Banerjee, K., Letterio, J., Denning, T. L. & Oswald-Richter, K. et al. Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. J. Clin. Invest. 116, 916–28 (2006).
doi: 10.1172/JCI27203
Burton, O. T., Zaccone, P., Phillips, J. M., De La Pena, H., Fehervari, Z. & Azuma, M. et al. Roles for TGF-beta and programmed cell death 1 ligand 1 in regulatory T cell expansion and diabetes suppression by zymosan in nonobese diabetic mice. J. Immunol. 185, 2754–62 (2010).
doi: 10.4049/jimmunol.1001365
Reis e Sousa, C., Stahl, P. D. & Austyn, J. M. Phagocytosis of antigens by Langerhans cells in vitro. J. Exp. Med. 178, 509–19 (1993).
doi: 10.1084/jem.178.2.509
Samarasinghe, R., Tailor, P., Tamura, T., Kaisho, T., Akira, S. & Ozato, K. Induction of an anti-inflammatory cytokine, IL-10, in dendritic cells after toll-like receptor signaling. J. Interferon Cytokine Res. 26, 893–900 (2006).
doi: 10.1089/jir.2006.26.893
Saijo, K., Schmedt, C., Su, I. H., Karasuyama, H., Lowell, C. A. & Reth, M. et al. Essential role of Src-family protein tyrosine kinases in NF-kappaB activation during B cell development. Nat. Immunol. 4, 274–9 (2003).
doi: 10.1038/ni893
Goodridge, H. S., Simmons, R. M. & Underhill, D. M. Dectin-1 stimulation by Candida albicans yeast or zymosan triggers NFAT activation in macrophages and dendritic cells. J. Immunol. 178, 3107–15 (2007).
doi: 10.4049/jimmunol.178.5.3107
Slack, E. C., Robinson, M. J., Hernanz-Falcon, P., Brown, G. D., Williams, D. L. & Schweighoffer, E. et al. Syk-dependent ERK activation regulates IL-2 and IL-10 production by DC stimulated with zymosan. Eur. J. Immunol. 37, 1600–12 (2007).
doi: 10.1002/eji.200636830
Li, H., Gonnella, P., Safavi, F., Vessal, G., Nourbakhsh, B. & Zhou, F. et al. Low dose zymosan ameliorates both chronic and relapsing experimental autoimmune encephalomyelitis. J. Neuroimmunol. 254, 28–38 (2013).
doi: 10.1016/j.jneuroim.2012.08.013
Wakim, L. M., Woodward-Davis, A. & Bevan, M. J. Memory T cells persisting within the brain after local infection show functional adaptations to their tissue of residence. Proc. Natl. Acad. Sci. USA 107, 17872–9 (2010).
doi: 10.1073/pnas.1010201107
Li, X., Liu, Z., Jin, H., Fan, X., Yang, X. & Tang, W. et al. Agmatine protects against zymosan-induced acute lung injury in mice by inhibiting NF-kappaB-mediated inflammatory response. Biomed. Res. Int. 2014, 583736 (2014).
pubmed: 25243152 pmcid: 4163488

Auteurs

Irina Caminschi (I)

Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, VIC, Australia.

Mireille H Lahoud (MH)

Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, VIC, Australia.

Angela Pizzolla (A)

Department of Microbiology and Immunology, The University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, 3000, Australia.

Linda M Wakim (LM)

Department of Microbiology and Immunology, The University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, 3000, Australia. wakiml@unimelb.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH